Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Intraductal, Noninfiltrating × Omacor × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1

Interventions

Tamoxifen 4 Specimen Handling 4 ruxolitinib 1 exemestane 1 Omacor 1 Neoadjuvant Therapy 1 Letrozole 1 Decision Support Techniques 1 Cholecalciferol 1 Cannabidiol 1 Biopsy 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06195306 2026-04-13

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

National Cancer Institute (NCI)

Phase 2 Recruiting

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡